We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CRISPR Could Restore Effectiveness of Lung Cancer Treatment

News   Dec 18, 2018 | Original story from Christiana Care Health System

 
CRISPR Could Restore Effectiveness of Lung Cancer Treatment
 
 
Advertisement
 

RELATED ARTICLES

Scientists Use Novel Ink To 3D-Print Bone-Mimicking Structures

News

Scientists from UNSW Sydney have developed a ceramic-based ink that may allow surgeons in the future to 3D-print bone parts complete with living cells that could be used to repair damaged bone tissue.

READ MORE

Gene-Editing “Branches Out” With Engineered Variant of CRISPR-Cas9

News

Introducing SpRY, a newly engineered variant of the famed gene editing tool CRISPR-Cas9. SpRY essentially removes the barriers of what can and can't be targeted for gene editing, making it possible for the first time to target nearly any genomic sequence in plants for potential mutation.

READ MORE

Team Investigates Potential Drug Therapy Combination for Lung Cancer

News

Researchers report that in non-small-cell lung carcinoma, secondary mutations occurring with another gene alteration known as ALK make the efficacy of alectinib, an otherwise commonly used drug for treating lung cancer, become unfavorable. Combining alectinib with another drug could help to overcome these effects.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE